Summary A clinico-pathological study of 35 bronchial carcinoid tumours was undertaken. Age. T stage, N stage, lymph node involvement, number of lymph nodes involved and number of cigarettes smoked per day were the clinical variables affecting survival. The histological variables related to survival were; mitotic count, necrosis, nuclear pleomorphism, vascular and lymphatic permeation and an undifferentiated growth pattern. All these features could be detected with routine histological stains, whereas immunocytochemical methods for demonstrating neuron specific enolase were of no help in assessing the prognosis. However there was a tendency for a well differentiated neuroendocrine carcinoma to stain strongly in some areas with carcinoembryonic antigen.
Experience with the carcinoid tumour is limited since they account for between only 1 and 6% of all primary lung tumours (Editorial, 1981) . However because of its varied histological patterns it is probably under-diagnosed. Traditionally the lesion has been regarded as benign but it has become apparent that prognosis may be difficult to determine from the histological pattern (Abbey- Smith, 1969) . It has also been recently realised that there is a histological spectrum ranging from bronchopulmonary carcinoid tumours (typical carcinoids) through to small cell neuroendocrine carcinomas (Gould et al., 1983) . To determine if histology, histochemistry and immunocytochemistry were of any use in determining the prognosis, we retrospectively examined a series of bronchial carcinold tumours.
Materials and methods
The SNOP code of the histological files of the Pathology Department at the Regional Cardiothoracic Centre, Wythenshawe Hospital, Manchester were scanned for the diagnosis of carcinoid tumour or bronchial adenoma. The number of the population using the Office of Population Census and Surveys Monitor, (1983) .
Five ,um sections were cut and stained with haematoxylin and eosin (H&E), Grimelius (an argyrophil stain) and diastase PAS (to demonstrate neutral mucins). Sections were stained by the PAP technique (Sternberger, 1979) The results of each study (clinical and histopathological) were assessed independently and survival curves were calculated by the life table method and compared using the log rank test. Cox's regression analysis was used to identify continuous variables significantly related to survival (Peto et al., 1977 , Cox, 1972 .
Results
Fifty cases had the diagnosis of carcinoid tumour or adenoma. However the diagnosis was revised in 9 cases to haemangiopericytoma (1) small cell carcinoma (2) squamous cell carcinoma (3) squamous and small cell carcinoma (1) adenoid cystic carcinoma (1) and adenocarcinoma (1). Out of the 41 cases left, only 35 had notes available for follow-up. There were 17 bronchopulmonary carcinoid tumours (typical carcinoids) and 18 welldifferentiated neuroendocrine carcinomas.
There were 21 males and 14 females. The age range was 18-76 years with a mean of 52 years. Twenty patients had never smoked and 12 of the remaining patients smoked between 5 and 30 cigarettes a day. No smoking history was available in three cases. The number of smokers did not differ from the population smoking in the period 1972-1982 (10.91 chi-square test) . The size of the tumours ranged from 0.5cm to 8.0cm in diameter. The sites of the tumour were right (site not specified) 3, right upper lobe 2, right middle lobe 6, right lower lobe 8, left (site not specified) 6, left upper lobe 5 and left lower lobe 5. Twenty-seven tumours were central (i.e. involving a main bronchus) and 8 were peripheral. Bronchoscopy was positive in 21 patients and negative in 14. Twenty-two cases had a lobectomy and 12 a pneumonectomy. One case had the tumour treated by endobronchial resection. Twenty cases were T stage I, 12 T stage II and 3 T stage III. Twentyfour cases were N stage 0, 5 were N stage I and 6 N stage II. At the time of analysis 27 patients were alive with no evidence of disease, 1 patient was alive with residual tumour, 6 patients had died from their carcinoid tumours and 1 had died from myocardial infarction. The architecture was mixed in 22 cases, relatively few cases having a pure pattern. There were 6 cases with a pure insular pattern (Figure 1) (Figure 3 ) and this was also seen in 7 mixed cases. There were no cases with a pure acinar pattern but 11 cases had a acinar component (Figure 4) to the mixed cases.
Ten central carcinoid tumours were confined to the bronchial wall and 17 had extended beyond. Lymphatic invasion was seen in 8 cases and lymph node involvement in 9. In four cases no lymph nodes were received in the laboratory. There was perineural invasion in 3 cases. Necrosis was seen in 13 cases and nuclear pleomorphism in 18 cases. Vascular invasion was seen in 9 patients. Oncocytic change was present in 13 cases including one oncocytic carcinoid. The mitotic count was 5 or greater in 5 cases but 27 cases had no mitoses.
Grimelius stain was positive in 21 cases and negative in 14. Mucin, as shown by diastase/PAS was seen either in glandular lumina or occasionally inside the cytoplasm of cells and was present in 8 cases. NSE was positive in all but one case which was a well differentiated neuroendocrine carcinoma with much necrosis. When the antisera was omitted the slides did not stain positively. The rectal adenocarcinoma was positive for CEA. CEA showed strong or moderate ( Figure 5 ) though focal positivity in seven cases of well differentiated neuroendocrine carcinoma whereas it was negative or showed weak staining in the typical carcinoids. (McCaughan et al., 1985) patients with distal metastases were more commonly male and smokers. In another series 16/17 patients with atypical pulmonary carcinoids were smokers (Mills et al., 1982) . Thirty-seven of 156 patients in a third paper were smokers (Paladugu et al., 1985) .
There was little difference in the site of the tumour in our series though a slightly larger number was seen in the right lung. If several series are added together (Abbey-Smith, 1969 , Turnbull et al., 1972 , Okike et al., 1976 , Cooney et al., 1979 , McCaughan et al., 1982 In our study undifferentiated growth pattern was the worst prognostic feature but the mitotic count, nuclear pleomorphism and necrosis were also statistically significant as was vascular and lymphatic invasion. Lymph node metastases do not always imply a poor prognosis (Salyer et al., 1975) . However Hadju et al., (1974) reported decreased survival in metastatic deeply invasive bronchial carcinoids. Forty-one of their 204 cases were pulmonary. Deeply invasive was defined as a tumour involving 'halfway through the wall of the organ' or being larger than 2.5cm in diameter. Regional lymph node metastasis adversely affected survival in a recent series (McCaughan, 1985) .
Undifterentiated growth pattern had a highily significant affect on survival. Growth pattcerns in pulmonary and other carcinoids have been shown to be possibly related to the site of the tumour by Soga and Tazawa (1971 The numbers were too small in our study to sec if a similar pattern was seen in bronchial carcinoids.
NSE was positive in all but one of the cases. The case not staining was a neuroendocrine carcinoma with much necrosis. The positivity of carcinoid tumours with NSE is in accord with the experience of Shepherd et al. (1984) . However it should be noted that NSE is an unreliable stain for neuroendocrine cells and recently has been shown to be positive in tumours of non-endocrine origin (Vinores et al., 1984) . It is our experience that some adenocarcinomas and squamous cell tumours have stained positively with this antiserum. It will not differentiate bronchopulmonary carcinoid tumours from well-differentiated neuroendocrine carcinoma or small cell carcinomas. Unfortunately CEA will not do this either. CEA is positive in small ccil tumours (Sehested et al., 1981) and thus it is not surprising that it is seen in bronchial carcinoids which are part of the same biological spectrum. The antibody was located inside the cytoplasm as well as in glandular lumina. However in the well differentiated neuroendocrine carcinomas there was a tendency for strong cytoplasmic staining with CEA. While in some cases it was focal it may give a guide to biological behaviour of these tumours. Mucin staining tended to follow the same pattern as CEA but was less well defined in some cases.
Grimelius stain was positive in 21 cases and negative in 14. A histolopathologist must be prepared to diagnose a bronchial carcinoid in the face of a negative Grimelius. Argentaffin stains are rarely positive in bronchial carcinoids. Some authors (Blondal et al., 1980) found all their carcinoid tumours were argyrophil positive. Three tumours that did not stain were reclassified into mucoepidermoid carcinoma, cylindroma and an 'epidermoid' tumour. In a series of 17 atypical carcinoid tumours the number of argyrophil positive tumours was increased using a modified Pascual method (Mills et al., 1982) . As in other series the number of argyrophil positive cells varied from field to field, an important point when examining small biopsies. The converse point is also true that everything argyrophilic is not a carcinoid. Thus intracellular lactalbumin, lipofuschin, mucin and glycogen can all show a degree of argyrophilia (DeLellis et al., 1984) .
Finally the classification used may be questioned. If one accepts that NSE is not an ideal endocrine marker then it has not strictly been shown that neuroendocrine activity is present in many of our cases. Looking at Gould's definitions (1983) and figures it would appear that atypical carcinoids and probably the malignant carcinoid are equivalent to the well-differentiated neuroendocrine carcinoma. However in a series of 63 cases of bronchial carcinoid tumours currently being studied the malignant carcinoid usually shows many small cell areas and larger foci of necrosis than the atypical carcinoid where a very definite organoid pattern is seen. The advantage of the new classification is that the histological spectrum of carcinoid tumours is shown and perhaps conveys to the clinician, that like the transitional cell 'papilloma' of bladder, it is a tumour worthy of follow-up.
